Literature DB >> 8897017

Glucagon-like peptide-1(7-36) amide and glycogen synthesis in the liver.

Y Nakagawa, K Kawai, H Suzuki, S Ohashi, K Yamashita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8897017     DOI： 10.1007/bf02658516

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  10 in total

1.  Absence of insulinotropic glucagon-like peptide-I(7-37) receptors on isolated rat liver hepatocytes.

Authors:  P F Blackmore; S Mojsov; J H Exton; J F Habener
Journal:  FEBS Lett       Date:  1991-05-20       Impact factor: 4.124

2.  Potent glycogenic effect of GLP-1(7-36)amide in rat skeletal muscle.

Authors:  M L Villanueva-Peñacarrillo; A I Alcántara; F Clemente; E Delgado; I Valverde
Journal:  Diabetologia       Date:  1994-11       Impact factor: 10.122

3.  Glucagon-like peptide-1(7-37) does not stimulate either hepatic glycogenolysis or ketogenesis.

Authors:  Y Murayama; K Kawai; S Suzuki; S Ohashi; K Yamashita
Journal:  Endocrinol Jpn       Date:  1990-04

4.  Comparison of the effects of glucagon-like peptide-1-(1-37) and -(7-37) and glucagon on islet hormone release from isolated perfused canine and rat pancreases.

Authors:  K Kawai; S Suzuki; S Ohashi; H Mukai; H Ohmori; Y Murayama; K Yamashita
Journal:  Endocrinology       Date:  1989-04       Impact factor: 4.736

5.  Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal.

Authors:  D A D'Alessio; S E Kahn; C R Leusner; J W Ensinck
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Failure of GLP-1(7-36)amide to affect glycogenesis in rat skeletal muscle.

Authors:  C Fürnsinn; K Ebner; W Waldhäusl
Journal:  Diabetologia       Date:  1995-07       Impact factor: 10.122

7.  Functional expression of the rat glucagon-like peptide-I receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C.

Authors:  M B Wheeler; M Lu; J S Dillon; X H Leng; C Chen; A E Boyd
Journal:  Endocrinology       Date:  1993-07       Impact factor: 4.736

8.  Glucagon-like peptide 1: a potent glycogenic hormone.

Authors:  I Valverde; M Morales; F Clemente; M I López-Delgado; E Delgado; A Perea; M L Villanueva-Peñacarrillo
Journal:  FEBS Lett       Date:  1994-08-01       Impact factor: 4.124

9.  Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.

Authors:  M Gutniak; C Orskov; J J Holst; B Ahrén; S Efendic
Journal:  N Engl J Med       Date:  1992-05-14       Impact factor: 91.245

10.  Glucagon-like peptide-1 7-36: a physiological incretin in man.

Authors:  B Kreymann; G Williams; M A Ghatei; S R Bloom
Journal:  Lancet       Date:  1987-12-05       Impact factor: 79.321
  10 in total
  2 in total

1.  Effects of intraportal exenatide on hepatic glucose metabolism in the conscious dog.

Authors:  Dale S Edgerton; Zhibo An; Kathryn M S Johnson; Tiffany Farmer; Ben Farmer; Doss Neal; Alan D Cherrington
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-05-14       Impact factor: 4.310

Review 2.  Irisin and Incretin Hormones: Similarities, Differences, and Implications in Type 2 Diabetes and Obesity.

Authors:  Nicola Marrano; Giuseppina Biondi; Anna Borrelli; Angelo Cignarelli; Sebastio Perrini; Luigi Laviola; Francesco Giorgino; Annalisa Natalicchio
Journal:  Biomolecules       Date:  2021-02-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.